Jarvis.Infecciones hospitalarias_7ed.

18

Sección I • Consideraciones generales sobre las infecciones hospitalarias

66. Gordis L. Case-control and cross-sectional studies. En: Gordis L, ed. Epidemiology . W.B. Saunders; 2000:140-157. 67. Amoah J, Stuart E, Cosgrove S. Comparing propensity score methods versus traditional regression analysis for the evaluation of observational data: a case study evaluating the treatment of gram-negative bloodstream infections. Clin Infect Dis . 2020;71:e497-e505. 68. Gordis L. More on risk: estimating the potential for prevention. En: Gordis L, ed. Epidemiol ogy . W.B. Saunders; 2000:172-179. 69. Leviton A. Letter: definitions of attributable risk. Am J Epidemiol . 1973;98:231. 70. Freeman J. Modern quantitative epidemiology in the hospital. En: Mayhall CG, ed. Hospital Epidemiology and Infection Control . Williams & Wilkins; 1996:11-40. 71. Neuhäuser M. How to deal with multiple endpoints in clinical trials. Fundam Clin Pharma col . 2006;20:515-523. 72. Gordis L. Randomized trials: some further issues. En: Gordis L, ed. Epidemiology . W.B. Saun ders; 2000:110-128. 73. Gordis L. A pause for review: comparing cohort and case-control studies. En: Gordis L, ed. Epidemiology . W.B. Saunders; 2000:180-183. 74. Greenland S, Rothman KS. Measures of effect and measures of association. En: Rothman KJ, Greenland S, eds. Modern Epidemiology . Lippincott-Raven; 1998:47-64. 75. Buchholz U, Richards C, Murthy R, et al. Pyrogenic reactions associated with single daily dosing of intravenous gentamicin. Infect Control Hosp Epidemiol . 2000;21:771-774. 76. Ostrowsky BE, Whitener C, Bredenberg HK, et al. Serratia marcescens bacteremia traced to an infused narcotic. N Engl J Med . 2002;346:1529-1537. 77. Hennekens CH, Buring JE. Analysis of epidemiological studies: evaluating the role of bias. En: Hennekens CH, Buring JE, Mayrent SL, eds. Epidemiology in Medicine . Little, Brown; 1987:272-286. 78. Hennekens CH, Buring JE. Analysis of epidemiological studies: evaluating the role of con founding. En: Hennekens CH, Buring JE, Mayrent SL, eds. Epidemiology in Medicine . Little, Brown; 1987:287-323. 79. Harris AD, Pineles L, Belton B, et al. Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA . 2013;310:1571-1580. 80. Rothman KS, Greenland S. Types of epidemiological studies. En: Rothman KJ, Greenland S, eds. Modern Epidemiology . Lippincott-Raven; 1998:67-68. 81. Siegel JD, Rhinehart E, Jackson M, et al. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. CDC; 2007. https://www.cdc.gov/ infectioncontrol/guidelines/isolation/index.html

82. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: medi cal and public health management. Working Group on Civilian Biodefense. JAMA . 1999;281:2127-2137. 83. Varia M, Wilson S, Sarwal S, et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ . 2003;169:285-292. 84. Shaw K. The 2003 SARS outbreak and its impact on infection control practices. Public Health . 2006;120:8-14. 85. Centers for Disease Control and Prevention. Prevention strategies for seasonal influenza in healthcare settings, guidelines and recommendations. Acceso el 30 de octubre de 2018. https://www.cdc.gov/flu/professionals/infectioncontrol/healthcaresettings.htm 86. Centers for Disease Control and Prevention. Scientific brief: SARS-CoV-2 transmission. Acceso el 5 de octubre de 2020. https://www.cdc.gov/coronavirus/2019-ncov/more/ scientific-brief-sars-cov-2.html 87. Alsved M, Matamis A, Bohlin R, et al. Exhaled respiratory particles during singing and talk ing. Aerosol Sci Technol . 2020;54:1245-1248. 88. World Health Organization. Transmission of SARS-CoV-2: implications for infection prevention precautions. Scientific Brief . July 9, 2020. https://www.who.int/news-room/ commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention precautions 89. Smith MR, Schaefer MK, Kainer MA, et al. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med . 2013;369:1598-1609. 90. Schaefer MK, Perkins KM, Perz JF. Patient notification events due to syringe reuse and mi shandling of injectable medications by health care personnel—United States, 2012-2018: summary and recommended actions for prevention and response. Mayo Clin Proc . 2020; 95:243-254. 91. Jarashow MC, Terashita D, Balter S, Schwartz B. Notes from the field: Mycobacteria chimaera infections associated with heater-cooler unit use during cardiopulmonary bypass surgery— Los Angeles County, 2012-2016. MMWR Morb Mortal Wkly Rep. 2019;67:1428-1429. 92. Perkins KM, Reddy SC, Fagan R, Arduino MJ, Perz JF. Investigation of healthcare infection risks from water-related organisms: summary of CDC consultations, 2014-2017. Infect Con trol Hosp Epidemiol . 2019;40:621-626. 93. Croucher NJ, Didelot X. The application of genomics to tracing bacterial pathogen trans mission. Curr Opin Microbiol . 2015;23:62-67.

Copyright © 2024 Wolters Kluwer, Inc. Unauthorized reproduction of the content is prohibited.